Bi Nan
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Neoadjuvant Durvalumab and Chemotherapy Followed by Surgery/CRT and Durvalumab in Borderline Resectable Stage Non-small Cell Lung Cancer Stage III, Borderline Resectable Carcinoma | Phase 2 | 2025-07-01 |